189 related articles for article (PubMed ID: 10741908)
1. Expression of the angiogenic factor thymidine phosphorylase in human astrocytic tumors.
Takano S; Tsuboi K; Matsumura A; Tomono Y; Mitsui Y; Nose T
J Cancer Res Clin Oncol; 2000 Mar; 126(3):145-52. PubMed ID: 10741908
[TBL] [Abstract][Full Text] [Related]
2. Biological role of thymidine phosphorylase in human astrocytic tumors.
Tanioka K; Takeshima H; Hirano H; Kimura T; Nagata S; Akiyama S; Kuratsu J
Oncol Rep; 2001; 8(3):491-6. PubMed ID: 11295068
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer.
Fujiwaki R; Hata K; Iida K; Maede Y; Watanabe Y; Koike M; Miyazaki K
Acta Obstet Gynecol Scand; 1999 Sep; 78(8):728-34. PubMed ID: 10468067
[TBL] [Abstract][Full Text] [Related]
4. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor.
Hata K; Fujiwaki R; Nakayama K; Maede Y; Fukumoto M; Miyazaki K
Anticancer Res; 2000; 20(5C):3941-9. PubMed ID: 11268481
[TBL] [Abstract][Full Text] [Related]
5. Macrophage infiltration-associated thymidine phosphorylase expression correlates with increased microvessel density and poor prognosis in astrocytic tumors.
Yao Y; Kubota T; Sato K; Kitai R
Clin Cancer Res; 2001 Dec; 7(12):4021-6. PubMed ID: 11751496
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor expression in progression of cervical cancer: correlation with thymidine phosphorylase expression, angiogenesis, tumor cell proliferation, and apoptosis.
Fujiwaki R; Hata K; Iida K; Maede Y; Miyazaki K
Anticancer Res; 2000; 20(2B):1317-22. PubMed ID: 10810442
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase.
Fujiwaki R; Iida K; Kanasaki H; Ozaki T; Hata K; Miyazaki K
Hum Pathol; 2002 Feb; 33(2):213-9. PubMed ID: 11957147
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis.
Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M
Oncology; 2001; 60(1):72-80. PubMed ID: 11150912
[TBL] [Abstract][Full Text] [Related]
10. Expression of nitric oxide synthase isozymes (NOS I-III) by immunohistochemistry and DNA in situ hybridization. Correlation with macrophage presence, vascular endothelial growth factor (VEGF) and oedema volumetric data in 220 glioblastomas.
Ludwig HC; Feiz-Erfan I; Bockermann V; Behnke-Mursch J; Schallock K; Markakis E
Anticancer Res; 2000; 20(1A):299-304. PubMed ID: 10769671
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer.
van Triest B; Pinedo HM; Blaauwgeers JL; van Diest PJ; Schoenmakers PS; Voorn DA; Smid K; Hoekman K; Hoitsma HF; Peters GJ
Clin Cancer Res; 2000 Mar; 6(3):1063-72. PubMed ID: 10741735
[TBL] [Abstract][Full Text] [Related]
12. Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer.
Giatromanolaki A; Koukourakis MI; Stathopoulos GP; Kapsoritakis A; Paspatis G; Kakolyris S; Sivridis E; Georgoulias V; Harris AL; Gatter KC
Oncol Res; 2000; 12(1):33-41. PubMed ID: 11061344
[TBL] [Abstract][Full Text] [Related]
13. The role of thymidine phosphorylase (TP) mRNA expression in angiogenesis of prostate cancer.
Kikuno N; Yoshino T; Urakami S; Shigeno K; Kishi H; Hata K; Shiina H; Igawa M
Anticancer Res; 2003; 23(2B):1305-12. PubMed ID: 12820387
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
[TBL] [Abstract][Full Text] [Related]
15. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
[TBL] [Abstract][Full Text] [Related]
16. Thymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinoma.
Kojima H; Shijubo N; Abe S
Cancer; 2002 Feb; 94(4):1083-93. PubMed ID: 11920479
[TBL] [Abstract][Full Text] [Related]
17. Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas.
Bian XW; Du LL; Shi JQ; Cheng YS; Liu FX
Anal Quant Cytol Histol; 2000 Jun; 22(3):267-74. PubMed ID: 10872046
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor and neovascularization in astrocytic tumors.
Takekawa Y; Sawada T
Pathol Int; 1998 Feb; 48(2):109-14. PubMed ID: 9589474
[TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease.
Fukuda S; Shirahama T; Imazono Y; Tsushima T; Ohmori H; Kayajima T; Take S; Nishiyama K; Yonezawa S; Akiba S; Akiyama S; Ohi Y
Cancer; 1999 Mar; 85(6):1323-30. PubMed ID: 10189138
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic effect of thymidine phosphorylase on macrophages in glioblastoma multiforme.
Hirano H; Tanioka K; Yokoyama S; Akiyama S; Kuratsu J
J Neurosurg; 2001 Jul; 95(1):89-95. PubMed ID: 11455962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
